West Pharmaceutical Services ROE - Return on Equity 2010-2024 | WST

West Pharmaceutical Services return on equity for the quarter ending September 30, 2024 was 18.33.

  • West Pharmaceutical Services average return on equity for 2023 was 20.51, a 25.8% decline from 2022.
  • West Pharmaceutical Services average return on equity for 2022 was 27.64, a 3.36% decline from 2021.
  • West Pharmaceutical Services average return on equity for 2021 was 28.6, a 50.45% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

West Pharmaceutical Services ROE - Return on Equity 2010-2024 | WST

  • West Pharmaceutical Services average return on equity for 2023 was 20.51, a 25.8% decline from 2022.
  • West Pharmaceutical Services average return on equity for 2022 was 27.64, a 3.36% decline from 2021.
  • West Pharmaceutical Services average return on equity for 2021 was 28.6, a 50.45% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.